Table 1

Demographics and baseline disease characteristics

CharacteristicAll patients (n=205)
Sex, n (%)
 Female82 (40.0)
 Male123 (60.0)
Median (range) age, years35.0 (18.0–79.0)
Race, n (%)
 White166 (81.0)
 Asian28 (13.7)
 Multiracial*6 (2.9)
 Black or African American5 (2.4)
Median (range) disease duration, y ears3.9  (0.3–38.8)
Disease extent
 Left-sided colitis97 (47.3)
 Pancolitis (extensive)64 (31.2)
 Unknown44 (21.5)
Mean (SD) partial Mayo score6.4 (1.40)
Mean (SD) full Mayo score (n=92)8.7 (1.65)
Stool frequency score (SFS), n (%)
 SFS 0 (Normal)3 (1.5)
 SFS 1 (1–2 stools more than normal)16 (7.8)
 SFS 2 (3–4 stools more than normal)64 (31.2)
 SFS 3 (≥5 stools more than normal)122 (59.5)
Rectal bleeding score (RBS), n (%)
 RBS 0 (No blood seen)†6 (2.9)
 RBS 1 (Streaks of blood with stool less than half of the time)77 (37.6)
 RBS 2 (Obvious blood with stool most of the time)94 (45.9)
 RBS 3 (Blood alone passed)28 (13.7)
Endoscopic findings (n=92), n (%)
 Mild disease‡5 (5.4)
 Moderate disease§58 (63.0)
 Severe disease¶29 (31.5)
Physician global assessment (PGA), n (%)
 PGA 0 (Normal)1 (0.5)
 PGA 1 (Mild disease)1 (0.5)
 PGA 2 (Moderate disease)150 (73.2)
 PGA 3 (Severe disease)53 (25.9)
Concomitant medications, n (%)
 5-Aminosalicylates145 (70.7)
 Azathioprine93 (45.4)
 Corticosteroids80 (39.0)
 6-Mercaptopurine19 (9.3)
 Methotrexate6 (2.9)
  • *Defined as have ≥2 of American Indian or Alaska native, black or African-American, Native Hawaiian or other Pacific islander, White or Asian.

  • †The six patients with rectal bleeding subscore 0 were included in the analysis; no patient selection was performed for the analysis.

  • ‡Mild  disease = erythema , decreased vascular pattern, mild friability.

  • §Moderate  disease = marked  erythema , absent vascular pattern, friability, erosions.

  • ¶Severe  disease = spontaneous  bleeding , ulceration.